Presence of tumor-infiltrating CD8+ T cells and macrophages correlates to longer overall survival in patients undergoing isolated hepatic perfusion for uveal melanoma liver metastasis
Uveal melanoma is a malignant tumor of the eye that often metastasizes to the liver conferring poor prognosis. When comparing immune profiles in peripheral blood of untreated patients with uveal melanoma liver metastasis and healthy blood donors, it was observed that immune cells of uveal melanoma p...
Gespeichert in:
| Veröffentlicht in: | Oncoimmunology 2020-01, Vol.9 (1), p.1854519-1854519 |
|---|---|
| Hauptverfasser: | , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1854519 |
|---|---|
| container_issue | 1 |
| container_start_page | 1854519 |
| container_title | Oncoimmunology |
| container_volume | 9 |
| creator | Johansson, Junko Siarov, Jan Kiffin, Roberta Mölne, Johan Mattsson, Jan Naredi, Peter Olofsson Bagge, Roger Martner, Anna Lindnér, Per |
| description | Uveal melanoma is a malignant tumor of the eye that often metastasizes to the liver conferring poor prognosis. When comparing immune profiles in peripheral blood of untreated patients with uveal melanoma liver metastasis and healthy blood donors, it was observed that immune cells of uveal melanoma patients carried immunosuppressive features. Patient blood contained an increased content of CD14
+
HLA-DR
−/low
M-MDSCs and inflammatory CD16
+
monocytes, while their dendritic cells expressed lower levels of activation markers. Melanoma patients also harbored an enhanced fraction of CD4
+
Foxp3
+
regulatory T cells, while their effector T cells expressed lower levels of the activation marker HLA-DR. Biopsies from liver metastases were obtained from patients with uveal melanoma that subsequently underwent hyperthermic isolated hepatic perfusion (IHP) with melphalan. There were trends indicating a positive correlation between a high infiltration of CD8
+
T cells in metastases and an activated immune cell profile in blood. High metastatic infiltration of CD8
+
T cells and CD68
+
macrophages, but not of immunosuppressive CD163
+
macrophages, correlated to a longer overall survival in patients treated with IHP. Hence, while the immune system of patients with uveal melanoma shows signs of immunosuppression, the presence of activated immune cells may correlate to a longer survival, at least following IHP treatment. |
| doi_str_mv | 10.1080/2162402X.2020.1854519 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_hal_p</sourceid><recordid>TN_cdi_hal_primary_oai_HAL_hal_03116025v1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_34d830837ad8404b9c5633195c833851</doaj_id><sourcerecordid>2471532631</sourcerecordid><originalsourceid>FETCH-LOGICAL-c658t-251872c221cda4731ea6b59864ec66fb45de2dc1296d32d2cd3c814425de30063</originalsourceid><addsrcrecordid>eNp9ks1u1DAUhSMEolXpI4C8BFUp_kvibBDV8NNKlWBRJHaWx3Yyrhw72MlUfTJejxtmWnVYEEWKc-65n52bUxSvCT4nWOD3lNSUY_rznGIKkqh4RdpnxfGil0vh-ZP1UXGa8y2Gq8ZVzdqXxRFjjHPM2XHx-3uy2QZtUezQNA8xlS50zk9JTS70aPVJnKEbpK33Galg0KB0iuNG9TYjHVOyXk2wnCLyMfQ2obi1SXmP8py2bqs8cgGNALNhymgOxqY-LmSX49Jq0MYuZY1Gm7o5uxhQFxOatxZ6B8CHOCjkHWDhdVIZbpdfFS865bM93T9Pih9fPt-sLsvrb1-vVhfXpa4rMZW0IqKhmlKijeINI1bV66oVNbe6rrs1r4ylRhPa1oZRQ7VhWhDOKegMBsZOiqsd10R1K8fkBpXuZVRO_hVi6qVKcHpvJeNGMCxYo4yA4a5bDdNmpK20YExUBFjljpXv7DivD2j9PEqQ-llmIGGCMQX_h50fzIM1GiYIkz1oO6wEt5F93MqmYawVHADvdoDNP22XF9dy0TAjpMa02i6He7vfLMVfs82THFxefrsKNs5ZUt6QitGaLdZqZ4Uk5Jxs98gmWC75lA_5lEs-5T6f0Pfm6fc8dj2kEQwfdwaIYEyDuovJGzmpex9Tl1TQLkv2_z3-AI_F-FQ</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2471532631</pqid></control><display><type>article</type><title>Presence of tumor-infiltrating CD8+ T cells and macrophages correlates to longer overall survival in patients undergoing isolated hepatic perfusion for uveal melanoma liver metastasis</title><source>Taylor & Francis Open Access</source><source>PMC (PubMed Central)</source><source>DOAJ Directory of Open Access Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Johansson, Junko ; Siarov, Jan ; Kiffin, Roberta ; Mölne, Johan ; Mattsson, Jan ; Naredi, Peter ; Olofsson Bagge, Roger ; Martner, Anna ; Lindnér, Per</creator><creatorcontrib>Johansson, Junko ; Siarov, Jan ; Kiffin, Roberta ; Mölne, Johan ; Mattsson, Jan ; Naredi, Peter ; Olofsson Bagge, Roger ; Martner, Anna ; Lindnér, Per</creatorcontrib><description>Uveal melanoma is a malignant tumor of the eye that often metastasizes to the liver conferring poor prognosis. When comparing immune profiles in peripheral blood of untreated patients with uveal melanoma liver metastasis and healthy blood donors, it was observed that immune cells of uveal melanoma patients carried immunosuppressive features. Patient blood contained an increased content of CD14
+
HLA-DR
−/low
M-MDSCs and inflammatory CD16
+
monocytes, while their dendritic cells expressed lower levels of activation markers. Melanoma patients also harbored an enhanced fraction of CD4
+
Foxp3
+
regulatory T cells, while their effector T cells expressed lower levels of the activation marker HLA-DR. Biopsies from liver metastases were obtained from patients with uveal melanoma that subsequently underwent hyperthermic isolated hepatic perfusion (IHP) with melphalan. There were trends indicating a positive correlation between a high infiltration of CD8
+
T cells in metastases and an activated immune cell profile in blood. High metastatic infiltration of CD8
+
T cells and CD68
+
macrophages, but not of immunosuppressive CD163
+
macrophages, correlated to a longer overall survival in patients treated with IHP. Hence, while the immune system of patients with uveal melanoma shows signs of immunosuppression, the presence of activated immune cells may correlate to a longer survival, at least following IHP treatment.</description><identifier>ISSN: 2162-402X</identifier><identifier>ISSN: 2162-4011</identifier><identifier>EISSN: 2162-402X</identifier><identifier>DOI: 10.1080/2162402X.2020.1854519</identifier><identifier>PMID: 33344043</identifier><language>eng</language><publisher>United States: Taylor & Francis</publisher><subject>antigen ; Cancer and Oncology ; Cancer och onkologi ; CD68 ; CD8 ; Immunologi inom det medicinska området ; Immunology ; Immunology in the Medical Area ; isolated hepatic perfusion ; Life Sciences ; lymphocytes ; Oncology ; Original Research ; outcomes ; pd-1 ; surface ; T cells ; Uveal melanoma</subject><ispartof>Oncoimmunology, 2020-01, Vol.9 (1), p.1854519-1854519</ispartof><rights>2020 The Author(s). Published with license by Taylor & Francis Group, LLC. 2020</rights><rights>2020 The Author(s). Published with license by Taylor & Francis Group, LLC.</rights><rights>Attribution</rights><rights>2020 The Author(s). Published with license by Taylor & Francis Group, LLC. 2020 The Author(s)</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c658t-251872c221cda4731ea6b59864ec66fb45de2dc1296d32d2cd3c814425de30063</citedby><cites>FETCH-LOGICAL-c658t-251872c221cda4731ea6b59864ec66fb45de2dc1296d32d2cd3c814425de30063</cites><orcidid>0000-0002-8052-8301 ; 0000-0002-6598-5221 ; 0000-0002-2266-7629 ; 0000-0002-4058-1327 ; 0000-0001-5795-0355</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7733984/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7733984/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,2096,27479,27901,27902,53766,53768,59116,59117</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33344043$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://amu.hal.science/hal-03116025$$DView record in HAL$$Hfree_for_read</backlink><backlink>$$Uhttps://gup.ub.gu.se/publication/301002$$DView record from Swedish Publication Index$$Hfree_for_read</backlink></links><search><creatorcontrib>Johansson, Junko</creatorcontrib><creatorcontrib>Siarov, Jan</creatorcontrib><creatorcontrib>Kiffin, Roberta</creatorcontrib><creatorcontrib>Mölne, Johan</creatorcontrib><creatorcontrib>Mattsson, Jan</creatorcontrib><creatorcontrib>Naredi, Peter</creatorcontrib><creatorcontrib>Olofsson Bagge, Roger</creatorcontrib><creatorcontrib>Martner, Anna</creatorcontrib><creatorcontrib>Lindnér, Per</creatorcontrib><title>Presence of tumor-infiltrating CD8+ T cells and macrophages correlates to longer overall survival in patients undergoing isolated hepatic perfusion for uveal melanoma liver metastasis</title><title>Oncoimmunology</title><addtitle>Oncoimmunology</addtitle><description>Uveal melanoma is a malignant tumor of the eye that often metastasizes to the liver conferring poor prognosis. When comparing immune profiles in peripheral blood of untreated patients with uveal melanoma liver metastasis and healthy blood donors, it was observed that immune cells of uveal melanoma patients carried immunosuppressive features. Patient blood contained an increased content of CD14
+
HLA-DR
−/low
M-MDSCs and inflammatory CD16
+
monocytes, while their dendritic cells expressed lower levels of activation markers. Melanoma patients also harbored an enhanced fraction of CD4
+
Foxp3
+
regulatory T cells, while their effector T cells expressed lower levels of the activation marker HLA-DR. Biopsies from liver metastases were obtained from patients with uveal melanoma that subsequently underwent hyperthermic isolated hepatic perfusion (IHP) with melphalan. There were trends indicating a positive correlation between a high infiltration of CD8
+
T cells in metastases and an activated immune cell profile in blood. High metastatic infiltration of CD8
+
T cells and CD68
+
macrophages, but not of immunosuppressive CD163
+
macrophages, correlated to a longer overall survival in patients treated with IHP. Hence, while the immune system of patients with uveal melanoma shows signs of immunosuppression, the presence of activated immune cells may correlate to a longer survival, at least following IHP treatment.</description><subject>antigen</subject><subject>Cancer and Oncology</subject><subject>Cancer och onkologi</subject><subject>CD68</subject><subject>CD8</subject><subject>Immunologi inom det medicinska området</subject><subject>Immunology</subject><subject>Immunology in the Medical Area</subject><subject>isolated hepatic perfusion</subject><subject>Life Sciences</subject><subject>lymphocytes</subject><subject>Oncology</subject><subject>Original Research</subject><subject>outcomes</subject><subject>pd-1</subject><subject>surface</subject><subject>T cells</subject><subject>Uveal melanoma</subject><issn>2162-402X</issn><issn>2162-4011</issn><issn>2162-402X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>0YH</sourceid><sourceid>DOA</sourceid><recordid>eNp9ks1u1DAUhSMEolXpI4C8BFUp_kvibBDV8NNKlWBRJHaWx3Yyrhw72MlUfTJejxtmWnVYEEWKc-65n52bUxSvCT4nWOD3lNSUY_rznGIKkqh4RdpnxfGil0vh-ZP1UXGa8y2Gq8ZVzdqXxRFjjHPM2XHx-3uy2QZtUezQNA8xlS50zk9JTS70aPVJnKEbpK33Galg0KB0iuNG9TYjHVOyXk2wnCLyMfQ2obi1SXmP8py2bqs8cgGNALNhymgOxqY-LmSX49Jq0MYuZY1Gm7o5uxhQFxOatxZ6B8CHOCjkHWDhdVIZbpdfFS865bM93T9Pih9fPt-sLsvrb1-vVhfXpa4rMZW0IqKhmlKijeINI1bV66oVNbe6rrs1r4ylRhPa1oZRQ7VhWhDOKegMBsZOiqsd10R1K8fkBpXuZVRO_hVi6qVKcHpvJeNGMCxYo4yA4a5bDdNmpK20YExUBFjljpXv7DivD2j9PEqQ-llmIGGCMQX_h50fzIM1GiYIkz1oO6wEt5F93MqmYawVHADvdoDNP22XF9dy0TAjpMa02i6He7vfLMVfs82THFxefrsKNs5ZUt6QitGaLdZqZ4Uk5Jxs98gmWC75lA_5lEs-5T6f0Pfm6fc8dj2kEQwfdwaIYEyDuovJGzmpex9Tl1TQLkv2_z3-AI_F-FQ</recordid><startdate>20200101</startdate><enddate>20200101</enddate><creator>Johansson, Junko</creator><creator>Siarov, Jan</creator><creator>Kiffin, Roberta</creator><creator>Mölne, Johan</creator><creator>Mattsson, Jan</creator><creator>Naredi, Peter</creator><creator>Olofsson Bagge, Roger</creator><creator>Martner, Anna</creator><creator>Lindnér, Per</creator><general>Taylor & Francis</general><general>Taylor & Francis Group</general><scope>0YH</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>1XC</scope><scope>VOOES</scope><scope>5PM</scope><scope>ADTPV</scope><scope>AOWAS</scope><scope>F1U</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-8052-8301</orcidid><orcidid>https://orcid.org/0000-0002-6598-5221</orcidid><orcidid>https://orcid.org/0000-0002-2266-7629</orcidid><orcidid>https://orcid.org/0000-0002-4058-1327</orcidid><orcidid>https://orcid.org/0000-0001-5795-0355</orcidid></search><sort><creationdate>20200101</creationdate><title>Presence of tumor-infiltrating CD8+ T cells and macrophages correlates to longer overall survival in patients undergoing isolated hepatic perfusion for uveal melanoma liver metastasis</title><author>Johansson, Junko ; Siarov, Jan ; Kiffin, Roberta ; Mölne, Johan ; Mattsson, Jan ; Naredi, Peter ; Olofsson Bagge, Roger ; Martner, Anna ; Lindnér, Per</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c658t-251872c221cda4731ea6b59864ec66fb45de2dc1296d32d2cd3c814425de30063</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>antigen</topic><topic>Cancer and Oncology</topic><topic>Cancer och onkologi</topic><topic>CD68</topic><topic>CD8</topic><topic>Immunologi inom det medicinska området</topic><topic>Immunology</topic><topic>Immunology in the Medical Area</topic><topic>isolated hepatic perfusion</topic><topic>Life Sciences</topic><topic>lymphocytes</topic><topic>Oncology</topic><topic>Original Research</topic><topic>outcomes</topic><topic>pd-1</topic><topic>surface</topic><topic>T cells</topic><topic>Uveal melanoma</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Johansson, Junko</creatorcontrib><creatorcontrib>Siarov, Jan</creatorcontrib><creatorcontrib>Kiffin, Roberta</creatorcontrib><creatorcontrib>Mölne, Johan</creatorcontrib><creatorcontrib>Mattsson, Jan</creatorcontrib><creatorcontrib>Naredi, Peter</creatorcontrib><creatorcontrib>Olofsson Bagge, Roger</creatorcontrib><creatorcontrib>Martner, Anna</creatorcontrib><creatorcontrib>Lindnér, Per</creatorcontrib><collection>Taylor & Francis Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><collection>Hyper Article en Ligne (HAL) (Open Access)</collection><collection>PubMed Central (Full Participant titles)</collection><collection>SwePub</collection><collection>SwePub Articles</collection><collection>SWEPUB Göteborgs universitet</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Oncoimmunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Johansson, Junko</au><au>Siarov, Jan</au><au>Kiffin, Roberta</au><au>Mölne, Johan</au><au>Mattsson, Jan</au><au>Naredi, Peter</au><au>Olofsson Bagge, Roger</au><au>Martner, Anna</au><au>Lindnér, Per</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Presence of tumor-infiltrating CD8+ T cells and macrophages correlates to longer overall survival in patients undergoing isolated hepatic perfusion for uveal melanoma liver metastasis</atitle><jtitle>Oncoimmunology</jtitle><addtitle>Oncoimmunology</addtitle><date>2020-01-01</date><risdate>2020</risdate><volume>9</volume><issue>1</issue><spage>1854519</spage><epage>1854519</epage><pages>1854519-1854519</pages><issn>2162-402X</issn><issn>2162-4011</issn><eissn>2162-402X</eissn><abstract>Uveal melanoma is a malignant tumor of the eye that often metastasizes to the liver conferring poor prognosis. When comparing immune profiles in peripheral blood of untreated patients with uveal melanoma liver metastasis and healthy blood donors, it was observed that immune cells of uveal melanoma patients carried immunosuppressive features. Patient blood contained an increased content of CD14
+
HLA-DR
−/low
M-MDSCs and inflammatory CD16
+
monocytes, while their dendritic cells expressed lower levels of activation markers. Melanoma patients also harbored an enhanced fraction of CD4
+
Foxp3
+
regulatory T cells, while their effector T cells expressed lower levels of the activation marker HLA-DR. Biopsies from liver metastases were obtained from patients with uveal melanoma that subsequently underwent hyperthermic isolated hepatic perfusion (IHP) with melphalan. There were trends indicating a positive correlation between a high infiltration of CD8
+
T cells in metastases and an activated immune cell profile in blood. High metastatic infiltration of CD8
+
T cells and CD68
+
macrophages, but not of immunosuppressive CD163
+
macrophages, correlated to a longer overall survival in patients treated with IHP. Hence, while the immune system of patients with uveal melanoma shows signs of immunosuppression, the presence of activated immune cells may correlate to a longer survival, at least following IHP treatment.</abstract><cop>United States</cop><pub>Taylor & Francis</pub><pmid>33344043</pmid><doi>10.1080/2162402X.2020.1854519</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0002-8052-8301</orcidid><orcidid>https://orcid.org/0000-0002-6598-5221</orcidid><orcidid>https://orcid.org/0000-0002-2266-7629</orcidid><orcidid>https://orcid.org/0000-0002-4058-1327</orcidid><orcidid>https://orcid.org/0000-0001-5795-0355</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 2162-402X |
| ispartof | Oncoimmunology, 2020-01, Vol.9 (1), p.1854519-1854519 |
| issn | 2162-402X 2162-4011 2162-402X |
| language | eng |
| recordid | cdi_hal_primary_oai_HAL_hal_03116025v1 |
| source | Taylor & Francis Open Access; PMC (PubMed Central); DOAJ Directory of Open Access Journals; EZB-FREE-00999 freely available EZB journals |
| subjects | antigen Cancer and Oncology Cancer och onkologi CD68 CD8 Immunologi inom det medicinska området Immunology Immunology in the Medical Area isolated hepatic perfusion Life Sciences lymphocytes Oncology Original Research outcomes pd-1 surface T cells Uveal melanoma |
| title | Presence of tumor-infiltrating CD8+ T cells and macrophages correlates to longer overall survival in patients undergoing isolated hepatic perfusion for uveal melanoma liver metastasis |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T07%3A03%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_hal_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Presence%20of%20tumor-infiltrating%20CD8+%20T%20cells%20and%20macrophages%20correlates%20to%20longer%20overall%20survival%20in%20patients%20undergoing%20isolated%20hepatic%20perfusion%20for%20uveal%20melanoma%20liver%20metastasis&rft.jtitle=Oncoimmunology&rft.au=Johansson,%20Junko&rft.date=2020-01-01&rft.volume=9&rft.issue=1&rft.spage=1854519&rft.epage=1854519&rft.pages=1854519-1854519&rft.issn=2162-402X&rft.eissn=2162-402X&rft_id=info:doi/10.1080/2162402X.2020.1854519&rft_dat=%3Cproquest_hal_p%3E2471532631%3C/proquest_hal_p%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2471532631&rft_id=info:pmid/33344043&rft_doaj_id=oai_doaj_org_article_34d830837ad8404b9c5633195c833851&rfr_iscdi=true |